These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7278611)

  • 1. [Evaluation of peripheral lymphocytes in patients with solid malignant tumors].
    Rumi LS; Eugui EM; Balbiani RL; Barañao RI
    Medicina (B Aires); 1981; 41(2):132-6. PubMed ID: 7278611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
    García MS; Barañao RI; Fernández O; Rumi LS
    Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 4. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
    Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
    Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological studies on lymphocytes in respiratory diseases. I. Studies on the subpopulation of human peripheral blood lymphocytes in respiratory diseases (author's transl)].
    Mayumi T
    Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):60-73. PubMed ID: 687844
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of cancer patients with autologous lymphocytes pre-incubated with T.F. from long survivors.
    Fazio M; Negri L; Mastromatteo V; Pacchioni D; Calabrese F; Giacomasso S
    J Exp Pathol; 1987; 3(4):569-77. PubMed ID: 3454804
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
    Saiz-Garcia F; Rodriguez-Valverde V
    Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of Ia-like antigen bearing lymphocytes in patients with solid primary tumors.
    Cordiali-Fei P; Natali PG; Pecci G; Pellegrino MA; Ferrone S
    J Clin Lab Immunol; 1981 Nov; 6(3):197-9. PubMed ID: 6951050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
    Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
    Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immuno-oncologic monitoring of patients with bronchial carcinoma. IV. Aspects of the immunocompetence system].
    Mancuso M; Leonardo E; Sanfilippo B; Dogliotti C; De Simone M; De Bernochi P; Maggi G
    Minerva Med; 1985 Mar; 76(13):619-26. PubMed ID: 3873024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.
    Steele G; Wang BS; Richie J; Wilson RE; Ervin T; Yankee R; Fallon M; Mannick JA
    Cancer Res; 1980 Jul; 40(7):2377-82. PubMed ID: 6155992
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
    Seki N; Hoshino T; Kikuchi M; Hayashi A; Itoh K
    Cell Immunol; 1997 Feb; 175(2):101-10. PubMed ID: 9023415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
    Ito N; Nakamura H; Tanaka Y; Ohgi S
    Cancer; 1999 Jun; 85(11):2359-67. PubMed ID: 10357406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nucleolar antigen in human malignant tumors.
    Busch H; Busch RK; Chan PK; Daskal Y; Gyorkey F; Gyorkey P; Kobayashi M; Smetana K; Sudhakar S
    Transplant Proc; 1980 Mar; 12(1):99-102. PubMed ID: 6989059
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunogenic activity of the regional lymphoreticulum during primary cancer of the lung].
    Lenzini L; Barnabé R
    Folia Allergol (Roma); 1969; 16(6):524-34. PubMed ID: 5401365
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in immunoregulatory cells in lung cancer and smoking.
    Ginns LC; Miller LG; Goldenheim PD; Goldstein G; Bria WF
    J Clin Immunol; 1982 Jul; 2(3 Suppl):90S-94S. PubMed ID: 6982280
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detection of suppressor lymphocytes in the blood of oncological patients by using a 3-component lymphocyte mixed culture].
    Govallo VI
    Vopr Onkol; 1981; 27(9):30-6. PubMed ID: 6457445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the lymphocyte surface receptors isolated from the blood and tissue of malignant tumors].
    Bilynskiĭ BT; Volod'ko NA
    Eksp Onkol; 1986; 8(3):47-9. PubMed ID: 3720642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.